Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Bone Metabolic Markers, TRAP, and Zometa's Effect on Bone Metastasis Due to Lung Cancer

NCT00265200 is registered in ClinicalTrials.gov with University of Louisville as lead sponsor.

NCT NCT00265200
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00265200 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Bone Metabolic Markers, TRAP, and Zometa's Effect on Bone Metastasis Due to Lung Cancer
Lead sponsor
University of Louisville
Phase
Phase 2
Overall status
Terminated
Start date
February 28, 2005
Completion date
December 31, 2010
Enrollment
28 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

carcinoma, non-small cell lung, carcinoma, small cell lung, metastases